Current Drug Abuse Reviews

206 papers and 8.4k indexed citations i.

About

The 206 papers published in Current Drug Abuse Reviews in the last decades have received a total of 8.4k indexed citations. Papers published in Current Drug Abuse Reviews usually cover Cellular and Molecular Neuroscience (49 papers), Clinical Psychology (42 papers) and Pharmacology (41 papers) specifically the topics of Neurotransmitter Receptor Influence on Behavior (38 papers), Substance Abuse Treatment and Outcomes (32 papers) and Cannabis and Cannabinoid Research (27 papers). The most active scholars publishing in Current Drug Abuse Reviews are Joris C. Verster, Luke A. Downey, Aurora J.A.E. van de Loo, Félix Carvalho and Teresa Magalhães.

In The Last Decade

Fields of papers published in Current Drug Abuse Reviews

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Current Drug Abuse Reviews. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Current Drug Abuse Reviews

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Current Drug Abuse Reviews. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Current Drug Abuse Reviews with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025